Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels

被引:0
作者
S Rafiq
K Stevens
A J Hurst
A Murray
W Henley
M N Weedon
S Bandinelli
A M Corsi
J M Guralnik
L Ferruci
D Melzer
T M Frayling
机构
[1] Peninsula College of Medicine and Dentistry,Department of Medical and Surgical Critical Care
[2] School of Mathematics and Statistics,undefined
[3] University of Plymouth,undefined
[4] Laboratory of Clinical Epidemiology,undefined
[5] Italian National Research Council on Aging,undefined
[6] Geriatric Rehabilitation Unit,undefined
[7] ASF,undefined
[8] Tuscany Regional Health Agency,undefined
[9] I.O.T,undefined
[10] University of Florence,undefined
[11] Laboratory of Epidemiology,undefined
[12] Demography and Biometry,undefined
[13] National Institute on Aging,undefined
[14] Longitudinal Studies Section,undefined
[15] Clinical Research Branch,undefined
[16] Gerontology Research Center,undefined
[17] National Institute on Aging,undefined
来源
Genes & Immunity | 2007年 / 8卷
关键词
inflammation; genetics; aging;
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin-1-receptor antagonist (IL-1RA) modulates the biological activity of the proinflammatory cytokine interleukin-1 (IL-1) and could play an important role in the pathophysiology of inflammatory and metabolic traits. We genotyped seven single nucleotide polymorphisms (SNPs) that capture a large proportion of common genetic variation in the IL-1RN gene in 1256 participants from the Invecchiare in Chianti study. We identified five SNPs associated with circulating IL-1RA levels with varying degrees of significance (P-value range=0.016–4.9 × 10−5). We showed that this association is likely to be driven by one haplotype, most strongly tagged by rs4251961. This variant is only in weak linkage disequilibrium (r2=0.25) with a previously reported variable number of tandem repeats polymorphism (VNTR) in intron-2 although a second variant, rs579543, that tags the VNTR (r2=0.91), may also be independently associated with IL-1RA levels (P=0.03). We found suggestive evidence that the C allele at rs4251961 that lowers IL-1RA levels is associated with an increased IL-1β (P=0.03) level and may also be associated with interferon -γ (P=0.03), α-2 macroglobulin (P=0.008) and adiponectin (P=0.007) serum levels. In conclusion, common variation across the IL-1RN gene is strongly associated with IL-1RA levels.
引用
收藏
页码:344 / 351
页数:7
相关论文
共 157 条
  • [1] Witkin SS(2002)Influence of interleukin-1-receptor antagonist gene polymorphism on disease Clin Infect Dis 34 204-209
  • [2] Gerber S(1997)Interleukin 1 receptor antagonist (IL-1Ra) is an acute phase protein J Clin Invest 99 2930-2940
  • [3] Ledger WJ(2005)The origins of age-related proinflammatory state Blood 105 2294-2299
  • [4] Gabay C(2005)Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study Am Heart J 150 276-281
  • [5] Smith MF(1999)Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events Circulation 99 2079-2084
  • [6] Eidlen D(2004)Inflammatory markers and physical performance in older persons: the InCHIANTI study J Gerontol A Biol Sci Med Sci 59 242-248
  • [7] Arend WP(1994)Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group JAMA 271 1836-1843
  • [8] Ferrucci L(2004)IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy Reumatismo 56 62-73
  • [9] Corsi A(2000)Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene J Exp Med 191 303-312
  • [10] Lauretani F(2006)The P2X7 receptor: a key player in IL-1 processing and release J Immunol 176 3877-3883